MetaTrader
  • Mercati
  • Grafici & Idee
  • Algo
  • Notizie
  • Store
  • Broker
  • Scarica
  • Calendario Economico
  • Segnali di Trading
  • Terminale Web
  • English English
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Türkçe Türkçe
Marker Therapeutics, Inc. Common Stock

MRKR

#3671
Marker Therapeutics, Inc. Common Stock
1.48
-5.13%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
1.48
1.48
Intervallo Annuale
0.81
4.07
Variazione giornaliera
-5.13%
Variazione Mensile
-19.57%
Variazione di 6 mesi
+64.44%
Variazione Annuale
+1.37%
Chiusura Precedente
1.56
Open
1.48
Bid
Ask
Low
1.48
High
1.48
Volume
5
  1. Mercati
  2. Mercato Azionario Statunitense
  3. Salute
  4. MRKR
Open full chart

Financials

Overview Estratto Conto Statistics Dividends
Quarterly Annual
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25 TTM

Notizie

Investing Investing
MRKR
2026.02.09
Marker Therapeutics fissa la data per l’assemblea annuale degli azionisti 2026
Investing Investing
MRKR
2026.02.09
Marker Therapeutics sets date for 2026 annual shareholder meeting and proposal deadline
Zacks Zacks
MNKD FOLD MRKR KROS
2026.01.21
MRKR Stock Up Nearly 114% in 3 Months: Here's What You Need to Know
Zacks Zacks
IRWD RIGL SLNO MRKR
2026.01.08
Zacks Industry Outlook Highlights Soleno Therapeutics, Nektar Therapeutics, Rigel Pharmaceuticals, Ironwood Pharmaceuticals and Marker Therapeutics
Zacks Zacks
MRKR
2026.01.07
MARKER THERAPEUTICS, INC. (MRKR) Now Trades Above Golden Cross: Time to Buy?
Zacks Zacks
SLNO IRWD RIGL MRKR
2026.01.07
5 Small Drug Stocks to Buy as Industry Recovery Picks Up
Investing Investing
MRKR
2026.01.06
Marker Therapeutics mantiene il rating Buy da H.C. Wainwright
Investing Investing
MRKR
2026.01.06
Marker Therapeutics stock maintains Buy rating at H.C. Wainwright
Investing Investing
MRKR
2026.01.05
Brookline Capital alza il target di prezzo delle azioni Marker Therapeutics a $5,60
Investing Investing
MRKR
2026.01.05
Brookline Capital raises Marker Therapeutics stock price target to $5.60
Investing Investing
MRKR
2025.12.08
H.C. Wainwright conferma rating Buy sulle azioni di Marker Therapeutics
Investing Investing
MRKR
2025.12.08
H.C. Wainwright reiterates Buy rating on Marker Therapeutics stock

Mercati

  • Mercato Azionario Americano
  • Valute
  • Criptovalute
  • Metalli
  • Materie Prime

Grafici & Idee

  • Idee di Trading
  • Idee Educative
  • Grafici

MQL5 Community

  • Market
  • Segnali
  • Forum
  • Articoli
  • CodeBase

Notizie

  • Mercato Azionario Americano
  • Valute
  • Criptovalute
  • Metalli
  • Materie Prime

Broker

  • Tutti i Broker
  • Forex
  • Azioni
  • Metalli
MetaTrader 5
MQL5 Channels
Economic Calendar
Esclusione di Responsabilità e Informativa sui Rischi Termini di Utilizzo Contatti e richieste Legale
Copyright 2000-2026, MetaQuotes Ltd